Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes

Go back to Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes
VolitionRX Limited (NYSE: VNRX) Delayed: 0.50 +0.16 (47.06%)
Previous Close $0.34    52 Week High $5.86 
Open $0.65    52 Week Low $3.05 
Day High $0.72    P/E N/A 
Day Low $0.50    EPS $-0.45 
Volume 353,928,531